Boston Life Sciences, Inc. to Present at the 2007 Biotechnology Industry Organization's (BIO) Annual BIO International Conventio
May 01 2007 - 11:44AM
PR Newswire (US)
HOPKINTON, Mass., May 1 /PRNewswire-FirstCall/ -- Boston Life
Sciences, Inc. (NASDAQ:BLSI) today announced that Ken Rice,
Executive Vice President and Chief Financial Officer of Boston Life
Sciences, Inc., will be presenting a Company overview in the
Business Forum at the BIO International Convention Tuesday, May 8th
at 11:45am EDT. The conference is being held on May 6-9 at the
Boston Convention & Exhibition Center in Boston, MA. BIO is
widely known for the BIO International Convention, a four-day
annual biotechnology showcase that draws about 20,000 attendees.
The convention serves to educate the public and policymakers about
biotechnology, while fostering partnering meetings and other
business development activities that keep the industry growing.
About Boston Life Sciences, Inc. Boston Life Sciences, Inc. (BLSI)
is engaged in the research and clinical development of diagnostic
and therapeutic products for central nervous system (CNS)
disorders. ALTROPANE(R) molecular imaging agent is in Phase III
clinical trials for the diagnosis of Parkinson's Disease (PD) and
Phase II clinical trials for the diagnosis of Attention Deficit
Hyperactivity Disorder (ADHD). Cethrin(R), a
recombinant-protein-based drug designed to promote nerve repair
after acute spinal cord injury, has reported positive interim
results in a Phase I/IIa clinical trial. The company's research and
pre-clinical CNS programs include Inosine for the treatment of
spinal cord injury and stroke, a DAT blocker for the treatment of
Parkinson's disease, and a second generation technetium-based
molecular imaging agent for PD and ADHD. BLSI's current research
collaborations include Harvard Medical School and Children's
Hospital Boston. Contact: Sharon Correia -- 508-497-2360 ext 224
Boston Life Sciences, Inc. DATASOURCE: Boston Life Sciences, Inc.
CONTACT: Sharon Correia of Boston Life Sciences, Inc.,
+1-508-497-2360, ext. 224, Web site:
http://www.bostonlifesciences.com/
Copyright
Boston Life Sciences (NASDAQ:BLSI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Boston Life Sciences (NASDAQ:BLSI)
Historical Stock Chart
From Apr 2023 to Apr 2024